Over the past two months, that is how much time has passed since my article "GSK's Hidden Growth Engines Beyond HIV and Oncology," GSK's shares ( GSK ) ( GLAXF ) have risen by 12.5%.With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, and pharmaceutical companies.Allka Research' ...